Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Roche Launches New Light Cycler 96 System

Published: Wednesday, November 07, 2012
Last Updated: Wednesday, November 07, 2012
Bookmark and Share
System debuts at Conference of American Society of Human Genetics in San Francisco.

Roche has announced the global launch of its new LightCycler 96 System, which completes its portfolio of Real Time PCR instruments for life science research.

The system’s unique combination of innovative features will be premiered at the Annual Meeting of the American Society of Human Genetics (ASHG), which will be taking place in San Francisco from November 6 - 10.

The Light Cycler 96 System offers highly accurate, reproducible and fast data generation for researchers working in a wide range of fields such as gene expression and genetic variation research.

The system permits flexible adaptation of workflows to specific assay formats and throughput needs. It also provides guided navigation and intuitive software for first-time users as well as a full set of analytical capabilities for experienced operators.

The data generated by the system can be analyzed directly or remotely for translation to publication-ready results in line with MIQE guidelines.

“The LightCycler 96 System reflects more than a decade of Roche expertise and continuous innovation in PCR technology and brings the high quality and reliability of our PCR systems within the reach of every researcher,” said Gerd Haberhausen, Head of qPCR and Sample Preparation Systems.

Haberhausen continued, “The instrument’s new silver block ensures outstanding temperature homogeneity and therefore enables a maximum of data consistency and accuracy. In addition, the new Light Cycler 96 puts the user right at the center by providing highly intuitive, user-friendly software and interfaces.”

Thanks to its innovative glass fiber optics, the Light Cycler 96 System offers equal and simultaneous data capture from all 96 wells, while avoiding the signal variations commonly seen in systems that use optical scanning.

It is also calibration- free as it does not require a passive reference dye.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Blueprint Medicine, Roche Collaborate
Collaboration combines blueprint medicines' proprietary drug discovery platform and immunokinase expertise with Roche's cancer immunotherapy expertise.
Wednesday, March 16, 2016
Roche to Acquire Seragon Pharmaceuticals
Acquisition of Phase I program offers a potential new approach for hormone receptor-positive breast cancer.
Wednesday, July 02, 2014
Roche Recieves FDA Approval for Cervical Cancer Screening HPV Test
Expanded indication makes cobas HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older.
Friday, April 25, 2014
FDA Recommends Roche's HPV Test as Primary Screening Tool
Test will assess risk of cervical cancer of women 25 years and older.
Thursday, March 13, 2014
Roche's Troponin T Nominated for International Inventor Award
European Patent Office nominates the team of Klaus Hallermayer from Roche Penzberg, jointly with Prof. Hugo Katus from the University of Heidelberg.
Monday, June 11, 2012
New Findings in Drug-Induced Receptor Activity
The discovery that drugs targeting a single GPCR can differentially modulate distinct subsets of the receptor signaling repertoire is a very important step in drug discovery.
Wednesday, February 15, 2012
Ghent University will Use Roche's LightCycler® 1536 Instrument in the Field of HT PCR for Cancer Research
Roche and Ghent University enter agreement for the use of Roche's LightCycler® 1536 Instrument in various cancer research projects in Ghent.
Thursday, April 22, 2010
Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution
Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis.
Monday, November 09, 2009
Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche’s xCELLigence System
Göttingen University study utilizes xCELLigence system from Roche Applied Science for testing of virus-mediated cytopathogenicity.
Friday, May 01, 2009
Roche Nimblegen and Biogemma to Develop Sequence Capture Technology for High-Throughput Sequencing of Crop Genomes
The partnership will facilitate marker-assisted breeding programs to select the crops with desirable traits that will benefit human lives.
Tuesday, January 13, 2009
Synta and Roche Form Discovery, Development, and Commercialization Alliance in Inflammation
The alliance aims to develop new category of oral agents for the potential treatment of rheumatoid arthritis and other inflammatory diseases.
Monday, January 12, 2009
Roche Applied Science Introduces new xCELLigence RTCA MP Instrument
The xCELLigence RTCA MP allows high throughput online-measurement of cell activities without labeling.
Friday, December 05, 2008
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!